In clinical trials, a bridging test with a monovalent component vaccine can be used to compare the protective efficacy of this component vaccine in a combination vaccine.
In clinical trials, bridge trials with unit-priced vaccines can be used to compare the protective ability of this group of vaccines in a combined vaccine.